BIBW 2992, a novel irreversible EGFR/HER2 tyrosine kinase inhibitor, in chemonaive patients with adenocarcinoma of the lung and activating EGFR mutations Meeting Abstract
| Authors: | Yang, C. H.; Shih, J. Y.; Su, W. C.; Hsia, T. C.; Ho, C. L.; Dudek, A. Z.; Terlizzi, E.; Zhao, Y. H. M.; Shahidi, M.; Miller, V. A. |
| Abstract Title: | BIBW 2992, a novel irreversible EGFR/HER2 tyrosine kinase inhibitor, in chemonaive patients with adenocarcinoma of the lung and activating EGFR mutations |
| Meeting Title: | 13th World Conference on Lung Cancer (IASLC) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 4 |
| Issue: | 9 Suppl. 1 |
| Meeting Dates: | 2009 Jul 31-Aug 4 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2009-09-01 |
| Start Page: | S294 |
| End Page: | S295 |
| Language: | English |
| ACCESSION: | ISI:000269496000296 |
| PROVIDER: | wos |
| DOI: | 10.1097/JTO.0b013e3181b9c77e |
| PUBMED: | 19704333 |
| Notes: | --- - Meeting Abstract: A3.3 - Suppl. 1 - "Source: Wos" |
